About Index Trending news
Lists
Pricing
SV Life Sciences

SV Life Sciences

SV Life Sciences

Life Sciences Venture Capital firm focused on selectively investing in biotech, medical devices and health-care services.

Elsewhere

Alexa global traffic share

Twitter followers

Investment profile

Geographical Focus
United States
Markets focus
Health Care Biotechnology Medical Devices
Stage Focus

Activity

Past year's investments
  • 3 rounds in the past year
  • $38,000,000 deployed in total
  • $12,666,667 avg per round
Latest rounds
  • PULMOCIDE LIMITED: Venture capital (Series B) ($30M)
  • Bardy Diagnostics: Venture capital (Undisclosed amount)
  • Pionyr Immunotherapeutics: Venture capital (Series A) ($8M)
Total funding
$121M in 4 rounds from 9 investors
By SV Life Sciences
$50M Venture capital in Dec, 2014
Total funding
$100.3M in 8 rounds from 18 investors
By SV Life Sciences
$38M Series D in Aug, 2015
Total funding
$60M in 3 rounds from 7 investors
By SV Life Sciences
$14M Series B in Apr, 2012
Total funding
$32.1M in 4 rounds from 14 investors
By SV Life Sciences
$14M Venture capital in Apr, 2012
Total funding
$182M in 7 rounds from 17 investors
By SV Life Sciences
$35M Series E in Aug, 2011
Total funding
$75.4M in 4 rounds from 4 investors
By SV Life Sciences
$12.4M Series A in Jan, 2015
Total funding
$109.2M in 7 rounds from 23 investors
By SV Life Sciences
$2.4M Debt financing in May, 2014
Total funding
$78.8M in 5 rounds from 16 investors
By SV Life Sciences
$26M Series D in Dec, 2013
Total funding
$73.3M in 5 rounds from 15 investors
By SV Life Sciences
$32.4M Series B in Nov, 2013
Total funding
$19.3M in 1 rounds from 5 investors
By SV Life Sciences
$19.3M Venture capital in Aug, 2009
Exit Invisalign, Mar 29, 2011
Total funding
$195M in 3 rounds from 6 investors
By SV Life Sciences
$15M Series B in Jan, 2016
Total funding
$51M in 6 rounds from 10 investors
By SV Life Sciences
$32M Series C in Jul, 2016
Total funding
$20M in 2 rounds from 7 investors
By SV Life Sciences
$20M Series B in Mar, 2005
Exit Amgen Inc., Jun 6, 2007
Total funding
$12.4M in 3 rounds from 3 investors
By SV Life Sciences
$11.9M Series A in Aug, 2016
Total funding
$25M in 1 rounds from 3 investors
By SV Life Sciences
$25M Series A in Aug, 2016
Total funding
$33.2M in 1 rounds from 6 investors
By SV Life Sciences
$33.2M Series A in Sep, 2016
Total funding
$34M in 1 rounds from 5 investors
By SV Life Sciences
$34M Venture Capital in Nov, 2016
Total funding
An undisclosed amount in 1 rounds from 4 investors
By SV Life Sciences
undisclosed deal in Jan, 2017
Total funding
$8M in 1 rounds from 4 investors
By SV Life Sciences
$8M Series A in Jan, 2017
Total funding
$57.5M in 2 rounds from 6 investors
By SV Life Sciences
$30M Series B in Mar, 2017

Want to see the complete list?
Go Pro!